Lorraine Marie Item

Dr. Lorraine Marie Item


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 September 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
HAHajar Fauzan Ahmad
Hajar Fauzan Ahmad
LILorraine Marie Item
Lorraine Marie Item
GDGretel G. Dema-Ala
Gretel G. Dema-Ala
NZNur Zawani Ahmad Zahir
Nur Zawani Ahmad Zahir
NTNorain Mohd Tamsir
Norain Mohd Tamsir
SOSeok Fang Oon
Seok Fang Oon
Background: Early-life gut microbiota plays a fundamental role in immune and metabolic development. Although probiotics have been widely investigated in paediatric populations, evidence regarding microbial cell preparation (MCP)-associated probiotic formulations, in which selected probiotic strains are incorporated into a standardized microbial preparation, remains fragmented. Objectives: This narrative review synthesizes current evidence on the potential role of MCP-associated strains in supporting gut health, immune modulation, and clinical outcomes in infants and children. Methods: A narrative literature review was conducted comprising peer-reviewed articles identified from major scientific databases. Grey literature, including unpublished conference presentations and institutional research materials, was also included. Studies were selected based on their relevance to the functional properties and clinical applications in paediatric populations. Results: Available evidence suggests that MCP-associated strains, including Lactobacillus acidophilus, Lactobacillus casei, Lactobacillus lactis, Bifidobacterium longum, Bifidobacterium bifidum, and Bifidobacterium infantis, contribute to improve gut barrier function, enrich healthy microbial composition, and modulate immune homeostasis through the production of short-chain fatty acids (SCFAs), bacteriocins, and exopolysaccharides. Clinical evidence has suggested potential benefits in growth outcomes among small-for-gestational-age (SGA) infants, reduction in the duration of certain infectious episodes, and prevention of selected neonatal and paediatric infections, with a favourable safety and tolerability profile. Conclusions: MCP-associated probiotic interventions may have potential roles as adjunctive therapies in paediatric care, supporting gut and immune health and contributing to the growing body of evidence in this field. Further multidisciplinary research is required to establish standardized protocols and strengthen the evidence base for microbiome-targeted therapeutics in children.